CD44 and lung cancer: In this study, we found that E2 increased RNF4 to reduce the Sp1 level, thereby enhancing CD44 expression through downregulation of miRNAs, leading to a poor prognosis in young women with lung cancer (Fig. 9D); this finding may be beneficial for developing therapeutic strategies in the future.